Premium
P3‐029: EFFICACY AND SAFETY OF OXIRACETAM IN PATIENTS WITH VASCULAR COGNITIVE IMPAIRMENT (OVERCOME): DESIGN AND RATIONALE FOR A MULTICENTER, RANDOMIZED, DOUBLE‐BLINDED, PLACEBO‐CONTROLLED, PARALLEL‐DESIGN, PHASE IV CLINICAL TRIAL
Author(s) -
Bae Hee-Joon,
Lim Jae-Sung,
Kim Beom Joon,
Park Jong-Moo,
Lee Kyung Bok,
Kim Dong-Eog,
Heo Jae-Hyeok,
Park Tai Hwan,
Cha Jae-Kwan,
Oh Mi-Sun,
Yu Kyung-Ho,
Lee Byung-Chul,
Park Hyuntae,
Kang Yeonwook,
Lee Juneyoung
Publication year - 2018
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2018.06.1384
Subject(s) - medicine , placebo , montreal cognitive assessment , cognitive decline , clinical dementia rating , stroke (engine) , vascular dementia , physical therapy , cardiology , dementia , pathology , mechanical engineering , alternative medicine , disease , engineering